A 50-year-old man undergoing treatment with 6-thioguanine for ulcerative colitis was admitted to the gastroenterology unit with suspected sinusoidal obstruction syndrome (SOS). Clinical diagnosis, made according to Seattle modified criteria and Baltimore criteria, was supported by magnetic resonance imaging (MRI) showing a diffuse patchy pattern in the portal phase (left, panel a), the "clover-like sign," in which liver parenchyma surrounding the main hepatic veins shows normal enhancement compared with the rest of the patchy enhanced area of liver (left, panel b), paraumbilical vein patency (left, panel c), and gallbladder wall thickening (left, panel d). Six months after 6-thioguanine was stopped, MRI showed complete resolution of the SOS; in particular, the patchy pattern disappeared (right, panel a), the hepatic veins were enhanced (right, panel b), the paraumbilical vein disappeared (right, panel c), and the gallbladder wall was normal (right, panel d). A 31-year-old man with a history of autoimmune thrombocytopenia and advanced Hodgkin's lymphoma presented with mild dysphagia for solid foods and a suspicious esophageal lesion detected by positron emission tomography with 2-deoxy-2-[fluorine-18]fluoro-d-glucose integrated with computed tomography ( 18 F-FDG PET/CT) performed during oncological follow-up. 18 F-FDG PET/CT identified abnormally increased FDG uptake (standardized uptake value = 4) in the middle third of the esophagus, which appeared slightly thickened and dilated in co-recorded CT images, with no other metabolically active lesions (a). Endoscopic ultrasound examination with fine-needle aspiration confirmed the presence of an oval mass covered by normalappearing mucosa and of a submucosal, homogeneous, hypoechoic lesion measuring 35 × 18 mm, whose cytology was compatible with the diagnosis of esophageal leiomyoma (b, hematoxylin and eosin staining, ×40; c, actin staining, ×40). After surgical removal, the diagnosis was confirmed by complete histological examination.
A 31-year-old man with a history of autoimmune thrombocytopenia and advanced Hodgkin's lymphoma presented with mild dysphagia for solid foods and a suspicious esophageal lesion detected by positron emission tomography with 2-deoxy-2-[fluorine-18]fluoro-d-glucose integrated with computed tomography ( 18 F-FDG PET/CT) performed during oncological follow-up. 18 F-FDG PET/CT identified abnormally increased FDG uptake (standardized uptake value = 4) in the middle third of the esophagus, which appeared slightly thickened and dilated in co-recorded CT images, with no other metabolically active lesions (a). Endoscopic ultrasound examination with fine-needle aspiration confirmed the presence of an oval mass covered by normalappearing mucosa and of a submucosal, homogeneous, hypoechoic lesion measuring 35 × 18 mm, whose cytology was compatible with the diagnosis of esophageal leiomyoma (b, hematoxylin and eosin staining, ×40; c, actin staining, ×40). After surgical removal, the diagnosis was confirmed by complete histological examination.
